Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Leukemia

  Free Subscription


27.07.2026

1 Acta Haematol
2 Am J Hematol
1 Biochem Pharmacol
2 Blood
1 BMC Cancer
5 Bone Marrow Transplant
1 Cancer
1 Cancer Lett
2 Eur J Haematol
1 Genes Chromosomes Cancer
1 J Pediatr Hematol Oncol
1 Leuk Lymphoma
1 Leuk Res
5 Leukemia


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. CHOI DH, Jang JH, Jung CW
    Inverted U-shaped relationship between pre-discontinuation TKI dose intensity and treatment-free remission outcome in chronic myeloid leukemia.
    Acta Haematol. 2026 Jul 23:1. doi: 10.1159.
    PubMed         Abstract available


    Am J Hematol

  2. OTHMAN T, Agrawal V, Song JY, Gu Z, et al
    Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia.
    Am J Hematol. 2026 Jul 23. doi: 10.1002/ajh.70450.
    PubMed         Abstract available

  3. BOLARINWA A, Al-Kali A, Alkhateeb HB, Mangaonkar AA, et al
    Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.
    Am J Hematol. 2026 Jul 18. doi: 10.1002/ajh.70443.
    PubMed         Abstract available


    Biochem Pharmacol

  4. YANG H, Liu Y, Yue C, Hao Y, et al
    Effect of Levofloxacin and moxifloxacin on arsenic metabolism and cardiotoxicity in APL patients treated with arsenic trioxide.
    Biochem Pharmacol. 2026;251.
    PubMed         Abstract available


    Blood


  5. Vekariya U, Toma M, Nieborowska-Skorska M, et al. DNA polymerase theta protects leukemia cells from metabolically induced DNA damage. Blood. 2023;141(19):2372-2389.
    Blood. 2026;148:522.
    PubMed        

  6. CERAN E, Jaramillo Segura S, Merbach AK, Rohde C, et al
    Inhibition of high CXCR4 with motixafortide and absence of single-cell MRD predict outcome after AML consolidation.
    Blood. 2026;148:545-559.
    PubMed         Abstract available


    BMC Cancer

  7. ABDILOVA G, Bazarbayeva A, Tashenova G, Karimova K, et al
    Incidence trends, mortality, and treatment-related toxicity in osteosarcoma, neuroblastoma, and acute lymphoblastic leukemia in Kazakhstan.
    BMC Cancer. 2026 Jul 21. doi: 10.1186/s12885-026-16570.
    PubMed         Abstract available


    Bone Marrow Transplant

  8. WIRK B, McCarty J
    Are all mismatched donors the same in allogeneic hematopoietic cell transplantation for secondary acute myeloid leukemia in the posttransplant cyclophosphamide era?
    Bone Marrow Transplant. 2026 Jul 24. doi: 10.1038/s41409-026-02996.
    PubMed        

  9. CARTA R, De Luca CD, Bertaina V, Gaspari S, et al
    Efficacy of blinatumomab for dermatomyositis/SLE overlap syndrome occurring after allogeneic hematopoietic stem cell transplant performed for acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2026 Jul 21. doi: 10.1038/s41409-026-02990.
    PubMed        

  10. BALEYDIER F, Galimard JE, Bernard F, Gonzales F, et al
    Is the adult EBMT risk score valid and relevant for hematopoietic stem cell transplantation in children acute leukemia?
    Bone Marrow Transplant. 2026 Jul 20. doi: 10.1038/s41409-026-02952.
    PubMed         Abstract available

  11. MAFFINI E, Labopin M, Raiola AM, Blaise D, et al
    Allogeneic hematopoietic cell transplantation from haploidentical donors with total body irradiation versus chemo-based regimens for adult AML patients in first complete remission. A study from the Acute Leukemia Working Party of the European Society
    Bone Marrow Transplant. 2026 Jul 20. doi: 10.1038/s41409-026-02988.
    PubMed         Abstract available

  12. PIERRI F, Bagnasco F, Saglio F, Fagioli F, et al
    Early inflammatory complications after haploidentical hematopoietic stem cell transplantation with post transplant cyclophosphamide for acute leukemia: a pediatric multicenter experience.
    Bone Marrow Transplant. 2026 Jul 18. doi: 10.1038/s41409-026-02976.
    PubMed         Abstract available


    Cancer

  13. KANTARJIAN H, Jen WY, Kugler E, Garris R, et al
    Results of second-line therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Cancer. 2026;132:e70533.
    PubMed         Abstract available


    Cancer Lett

  14. HINDES MT, McElligott AM, Best OG, Ward MP, et al
    Metabolic reprogramming, malignant transformation and metastasis: lessons from chronic lymphocytic leukaemia and prostate cancer.
    Cancer Lett. 2025 Jan 2:217441. doi: 10.1016/j.canlet.2025.217441.
    PubMed         Abstract available


    Eur J Haematol

  15. TAKAOKA K, Mott S, Yodsuwan R, Saowapa S, et al
    KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations.
    Eur J Haematol. 2026 Jul 24. doi: 10.1111/ejh.70270.
    PubMed         Abstract available

  16. RUSSO S, Capodanno I, Tiribelli M, Miggiano MC, et al
    Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.
    Eur J Haematol. 2026 Jul 22. doi: 10.1111/ejh.70268.
    PubMed         Abstract available


    Genes Chromosomes Cancer

  17. STENGEL A, Meggendorfer M, Haferlach T, Walter W, et al
    TP53 Amplification, a Rare but Recurrent Alteration in Myeloid Neoplasms.
    Genes Chromosomes Cancer. 2026;65:e70154.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  18. BALRAAM KV V, Nayak AR, Dass J, Chauhan R, et al
    Unresponsive Systemic Mastocytosis in a Young AML With RUNX1::RUNX1T1 Fusion With Rare KIT c.1255_1257delGAC Mutation: A Clinical Deadlock.
    J Pediatr Hematol Oncol. 2026;48:283-286.
    PubMed         Abstract available


    Leuk Lymphoma

  19. GLAIT SANTAR C, Katz BZ
    Philadelphia-negative B-cell acute lymphoblastic leukemia developing after treatment for multiple myeloma: a case report.
    Leuk Lymphoma. 2026 Jul 22:1-4. doi: 10.1080/10428194.2026.2693916.
    PubMed        


    Leuk Res

  20. XIE Z, Song Y, Zhang Y, Wang D, et al
    Analysis of the efficacy and safety of the IVD/EM maintenance regimen as post-remission treatment for adult patients with T-cell lymphoblastic lymphoma/leukemia.
    Leuk Res. 2026;168:108282.
    PubMed         Abstract available


    Leukemia

  21. KANTARJIAN H, Deininger M, Apperley JF, Arthur CK, et al
    Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.
    Leukemia. 2026 Jul 24. doi: 10.1038/s41375-026-03009.
    PubMed         Abstract available

  22. XU Q, Wang L, Liao N, Zheng M, et al
    Induction-phase blood arsenic concentration and relapse risk in pediatric acute promyelocytic leukemia treated with arsenic and all-trans retinoic acid.
    Leukemia. 2026 Jul 23. doi: 10.1038/s41375-026-03073.
    PubMed        

  23. LIANG M, Pan Y, Saw NYL, Lu X, et al
    Cumulative disruption of regulatory genes precedes whole-chromosome gains in acute myeloid leukemia.
    Leukemia. 2026 Jul 23. doi: 10.1038/s41375-026-03069.
    PubMed        

  24. BOUCHER AC, Rosikiewicz W, Cotton A, Broadhurst AL, et al
    The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome.
    Leukemia. 2026 Jul 21. doi: 10.1038/s41375-026-03074.
    PubMed         Abstract available

  25. CHEN Z, Cai Y, Wang Y, Lai X, et al
    G3BP2 confers venetoclax resistance by stabilizing ELF1-mediated MCL1 transcription in acute myeloid leukemia.
    Leukemia. 2026 Jul 20. doi: 10.1038/s41375-026-03063.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum